Literature DB >> 25461835

Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort.

Nicolae Sarbu1, Farah Alobeidi2, Pilar Toledano3, Gerard Espinosa3, Ian Giles4, Anisur Rahman4, Tarek Yousry2, Sebastian Capurro1, Rolf Jäger2, Ricard Cervera3, Nuria Bargalló5.   

Abstract

OBJECTIVES: To describe brain magnetic resonance imaging (MRI) abnormalities in newly diagnosed neuropsychiatric lupus (NPSLE). To correlate them with clinical and laboratory data.
METHODS: This retrospective cross-sectional study included patients presenting NPSLE undergoing brain MRI within 6 months after onset between 2003 and 2012. Clinical and laboratory data were recorded. MRI findings were defined as inflammatory-like, large-vessel disease (LVD), and small-vessel disease (SVD); SVD was classified as white-matter hyperintensities (WMH), recent small subcortical infarcts, lacunes, microbleeds, and brain atrophy.
RESULTS: We included 108 patients (mean 40.6 ± 14.2 years; range 14-77), 91.7% women. The most frequent syndromes were headache (28.5%), cerebrovascular disease (15.5%), seizure (15.5%), and cognitive dysfunction (11.4%). Brain abnormalities were found in 59.3%. SVD was the most common (55.6%), followed by LVD (13%) and inflammatory-like lesions (6.5%). The most frequent SVD findings were WMH (53.7%), atrophy (18.5%), microbleeds (13.7%) and lacunes (11.1%). Cerebrovascular syndrome correlated with LVD (p = 0.001) and microbleeds (p = 0.002), cognitive dysfunction with WMH (p = 0.045) and myelopathy with inflammatory-like lesions (p = 0.020). Low C4 and CH50 correlated with inflammatory-like lesions (p < 0.001, p = 0.019) and lupus anticoagulant with WMH (p = 0.018), microbleeds (p = 0.002) and atrophy (p = 0.008).
CONCLUSIONS: Vascular disease is the hallmark of NPSLE. Certain syndromes and immunological patterns are prone to more extensive brain damage. MRI could provide significant clinical information and insights into the pathological substrate.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Low complement levels; Lupus anticoagulant; Magnetic resonance imaging; Neuropsychiatric disorders; Systemic lupus erythematosus

Mesh:

Year:  2014        PMID: 25461835     DOI: 10.1016/j.autrev.2014.11.001

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  34 in total

Review 1.  The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface.

Authors:  Ariel D Stock; Sivan Gelb; Ofer Pasternak; Ayal Ben-Zvi; Chaim Putterman
Journal:  Autoimmun Rev       Date:  2017-04-17       Impact factor: 9.754

2.  Correlation of neurocognitive function and brain lesion load on magnetic resonance imaging in systemic lupus erythematosus.

Authors:  Paola C Roldan; Rex E Jung; Wilmer L Sibbitt; Clifford R Qualls; Ranee A Flores; Carlos A Roldan
Journal:  Rheumatol Int       Date:  2018-06-13       Impact factor: 2.631

Review 3.  Neuropsychiatric lupus: new mechanistic insights and future treatment directions.

Authors:  Noa Schwartz; Ariel D Stock; Chaim Putterman
Journal:  Nat Rev Rheumatol       Date:  2019-03       Impact factor: 20.543

Review 4.  Autoimmune diseases of the brain, imaging and clinical review.

Authors:  Ghazal Shadmani; Tyrell J Simkins; Reza Assadsangabi; Michelle Apperson; Lotfi Hacein-Bey; Osama Raslan; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2021-09-07

5.  Decreased Coupling Between Functional Connectivity Density and Amplitude of Low Frequency Fluctuation in Non-Neuropsychiatric Systemic Lupus Erythematosus: a Resting-Stage Functional MRI Study.

Authors:  Xiao Dong Zhang; Xiao Lu Jiang; Zhen Cheng; Yan Zhou; Qiang Xu; Zhi Qiang Zhang; Rongfeng Qi; Song Luo; Yan Su Yun; Hui Juan Chen; Xiang Kong; Guang Ming Lu; Long Jiang Zhang
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

Review 6.  Adipose-Derived Mesenchymal Stem Cells in Autoimmune Disorders: State of the Art and Perspectives for Systemic Sclerosis.

Authors:  Alexandre T J Maria; Marie Maumus; Alain Le Quellec; Christian Jorgensen; Danièle Noël; Philippe Guilpain
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 7.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 8.  The role of B cells and autoantibodies in neuropsychiatric lupus.

Authors:  Jing Wen; Ariel D Stock; Samantha A Chalmers; Chaim Putterman
Journal:  Autoimmun Rev       Date:  2016-07-05       Impact factor: 9.754

Review 9.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Authors:  Michel Toledano; Brian G Weinshenker; Andrew J Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 6.030

10.  Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus?

Authors:  V Balajkova; M Olejarova; R Moravcova; P Kozelek; M Posmurova; H Hulejova; L Senolt
Journal:  Physiol Res       Date:  2020-03-23       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.